SilverScript Reduces Costs For Diabetes Treatments

SilverScript is helping to reduce costs in 2018 for members who receive treatment for diabetes.

Three long-acting injectable insulin products will be on SilverScript’s 2018 Choice formulary as Tier 2 drugs, representing a nearly 60% savings over 2017 pricing on a 30-day supply when filled at a Choice Preferred Network Pharmacy.

Medicare beneficiaries should speak with their doctors to determine which of the following lower-cost alternatives might be right for them:

  • Basaglar® (prefilled pen injectors)
  • Levemir® (prefilled pen injectors or vials)
  • Tresiba® (prefilled pen injectors)

Please note that these three long-acting insulins will replace Lantus and Toujeo, which will no longer be on the formulary for 2018.

 

Details about the lower copay insulins:

 

For more information, contact your Cornerstone representative.

SilverScript’s First Look at 2018 Plan Benefits

Silverscript

SilverScript’s 2018 plan benefits are now available! Click below to get a first look at their plan details.

Please include your name, email address, and the state(s) you are requesting.

Not appointed with SilverScript? Contact your Cornerstone representative today to get started!